The success of this strategy is confirmed by the subsequent validation of the identified panel (FBP1, PDK4, RHCG) in independent kidney tissue cohorts, where it achieved excellent performance in distinguishing DKD from controls. The gene discussed is FBP1; the disease is diabetic kidney disease.